ESC 2025 29 August - 1 September 2025

Effects of semaglutide in patients with type 2 diabetes and peripheral artery disease: An analysis of the STRIDE trial stratified by disease severity and age

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Cardiovascular Disease
Congress oral presentation
GLP-1 RA
Semaglutide